| Doris Fong, | |
|
1781 Mill Stream Dr, Chino Hills, CA 91709-4882 | |
| (626) 679-7380 | |
| Not Available |
| Full Name | Doris Fong |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1781 Mill Stream Dr, Chino Hills, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235618760 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 54911 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Doris Fong, 1781 Mill Stream Dr, Chino Hills, CA 91709-4882 Ph: () - | Doris Fong, 1781 Mill Stream Dr, Chino Hills, CA 91709-4882 Ph: (626) 679-7380 |
News Archive
Under the most recent cost-saving budget proposals, 327 adult day healthcare centers throughout California would be eliminated. Cuts could save the state $135 million in fiscal 2011, state projections show.
In accordance with the consensus of the Global Conference held in Geneva on 10-11 December 2015, the World Organisation for Animal Health and the World Health Organization are releasing their global framework for the elimination of dog-mediated human rabies, in collaboration with the Food and Agriculture Organization of the United Nations and with the support of the Global Alliance for Rabies Control.
New Phase II data, published today in the New England Journal of Medicine, showed that Eli Lilly and Company's ixekizumab, an anti-IL-17 monoclonal antibody, met its primary endpoint in patients with moderate-to-severe plaque psoriasis, with significantly more patients achieving at least a 75 percent improvement in Psoriasis Area and Severity Index (PASI) scores from baseline (PASI 75) compared with placebo at week 12.
A groundbreaking study led by engineering and medical researchers at the University of Minnesota Twin Cities shows how engineered immune cells used in new cancer therapies can overcome physical barriers to allow a patient's own immune system to fight tumors.
Novel abnormalities in the FGFR gene, called FGFR fusions, were identified in a spectrum of cancers, and preliminary results with cancer cells harboring FGFR fusions suggested that some patients with these cancers may benefit from treatment with FGFR inhibitor drugs, according to data published in Cancer Discovery, a journal of the American Association for Cancer Research.
› Verified 1 days ago
Kaini Lee, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3320 Chino Hills Pkwy, Chino Hills, CA 91709 Phone: 909-393-9056 | |
Nilima Paul, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13181 Peyton Dr, Chino Hills, CA 91709 Phone: 909-627-5099 Fax: 909-464-1266 | |
Isabella A Fregoso, RPH, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1949 Paseo Grande, Chino Hills, CA 91709 Phone: 909-573-9220 | |
Cheryl Potvin, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15970 Los Serranos Country Club Dr, Chino Hills, CA 91709 Phone: 909-606-8185 | |
Kayla Arakaki, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3100 Chino Hills Pkwy Unit 1234, Chino Hills, CA 91709 Phone: 916-214-7156 | |
Paul Mansour, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15782 Roan Rd, Chino Hills, CA 91709 Phone: 909-618-5252 | |
Eric Yang, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 16111 Watson Ct, Chino Hills, CA 91709 Phone: 562-412-1874 |